
|Articles|October 13, 2019
Metastatic Breast Cancer Awareness Day: What You Need to Know
Author(s)Jessica Skarzynski
For Metastatic Breast Cancer Awareness Day on October 13th, 2019, here’s a round-up of fast facts and the latest news and updates in this disease space.
Advertisement
For Metastatic Breast Cancer Awareness Day on October 13th, 2019, here’s a round-up of fast facts and the latest news and updates in this disease space:
- Three-time cancer survivor and one-woman show writer and performer, Valerie David, sat down with CURE to discuss her experiences with non-Hodgkin lymphoma, then stage 2 breast cancer and, most recently, metastatic stage 4 breast cancer.
- After being diagnosed with metastatic breast cancer in January 2015, CURE contributor Martha Carlson shares some tips on how to responsibly search for healthcare information online.
- The Food and Drug Administration recently approved Piqray (alpelisib) for the treatment of certain postmenopausal women, and men, with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer.
- Eight-year metastatic “thriver” Stephanie Seban explains the hurdles she faced as she received the wrong treatment for nearly five years.
- In another FDA action, the subcutaneous use of Herceptin and Herceptin Hylecta in combination with chemotherapy was approved for the treatment of select patients with breast cancer.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows
2
Study Identifies Why Some Breast Cancers Resist Enhertu Treatment
3
FDA Accepts Ivonescimab Application for EGFR Lung Cancer
4
Ibrance Adds 15 Months of Progression-Free Survival in HR+, HER2+ Breast Cancer
5




